AI Article Synopsis
- A study focused on 13 patients with advanced HIV (CD4 count under 200 cells/μL) who also had severe mpox and multiple organ issues.* -
- These patients underwent long treatments with various medications, including tecovirimat and others, but still faced serious health complications.* -
- The outcomes showed that they had long hospital stays and a high death rate, highlighting the severity of their conditions.*
Article Abstract
Severe mpox has been observed in people with advanced human immunodeficiency virus (HIV). We describe clinical outcomes of 13 patients with advanced HIV (CD4 <200 cells/μL), severe mpox, and multiorgan involvement. Despite extended tecovirimat courses and additional agents, including vaccinia immune globulin, cidofovir, and brincidofovir, this group experienced prolonged hospitalizations and high mortality.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11168585 | PMC |
| http://dx.doi.org/10.1093/ofid/ofae294 | DOI Listing |
Publication Analysis
Top Keywords
severe mpox
8
people advanced
8
advanced human
8
human immunodeficiency
8
immunodeficiency virus
8
mpox people
4
virus receiving
4
receiving prolonged
4
prolonged tecovirimat
4
tecovirimat york
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!